HOME > INVESTOR > ARCHIVES > PRESS RELEASE
December 2011
Lupin receives final FDA Approval for Generic TRICOR®Tablets
Size: 107 Kb
Lupin receives Tentative Approval for Generic Cymbalta® Delayed-release Capsules
Size: 99 Kb
Lupin receives FDA Approval for Generic SOLODYN® Tablets
Size: 97 Kb


November 2011
Lupin Acquires I'rom Pharmaceuticals through its Japanese Subsidiary
Size: 97 Kb
Robust Growth, Record Profits Net Profit Up 24%, Q2 FY 2011-12
Size: 206 Kb


October 2011
Lupin receives Final FDA Approval for Generic LoSeasonique® Tablets
Size: 101 Kb
Lupin receives FDA approval for Generic KEPPRA® Oral Solution 100 mg / ml
Size: 99 Kb
Lupin launches Authorized Generic of Femcon® Fe
Size: 99 Kb


September 2011
Lupin Announces U.S. FDA Approval of its First Oral Contraceptive
Size: 100 Kb
Lupin Announces Launch of Generic KEPPRA XR® Tablets
Size: 137 Kb
Sanofi Aventis & Multicare Ink Strategic Agreement in the Philippines
Size: 92.5 Kb


August 2011
Lupin Receives Final Approval to Market Generic Ultram® ER
Size: 100 Kb


July 2011
Eli Lilly India and Lupin announce strategic collaboration to help fight the battle against diabetes
Size: 233 Kb
Consistent Growth, Net Sales up 17% India and Japan Drive Growth
Size: 223 Kb
Lupin Settles Ongoing Litigation with Medicis over Generic Versions of SOLODYN®
Size: 92 Kb
Lupin and Medicis Enter into Joint Development Agreement
Size: 74 Kb
Lupin announces tentative FDA Approval for Pregabalin Capsules
Size: 96 Kb
Lupin Launches Additional Strengths of Generic Lotrel® Capsules
Size: 95 Kb


June 2011
Lupin in Alliance with Natco to commercialize generic equivalent of Tykerb® Tablets
Size: 90 Kb
Lupin Announces Launch of Generic Levaquin® Tablets for the US Market
Size: 93 Kb
Lupin acquires Worldwide Rights for the Goanna® Brand
Size: 96 Kb
HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer
Size: 95 Kb
Lupin Announces Licensing Arrangement with NeuClone Inks strategic deal with NeuClone for Cell line Technology
Size: 54 Kb


May 2011
6 Years of Sustained Growth Lupin Net Profit up by 27% in FY 2010-11
Size: 435 Kb


April 2011
Lupin announces Patent License Agreement with Abbott
Size: 95.3 Kb
Lupin announces tentative FDA Approval for Metformin Hydrochloride extended-release tablets 500 mg and 1000 mg
Size: 91.3 Kb


March 2011
Lupin to donate Yen 10 mn. for Japan's earthquake victims
Size: 91.3 Kb


January 2011
Lupin Net Profit up by 39 % in Q3, FY 2010-11 Sustained Growth, Strong Profits.
Size: 329 Kb
Lupin Announces Final FDA Approval for Nabumetone tablets, 500 mg and 750 mg.
Size: 96.5 Kb
LUPIN signs strategic agreement with FARMANGUINHOS, Brazil
Size: 98.5 Kb
Lupin Settles all Ongoing Litigation with Sunovion over Generic of LUNESTA® (eszopiclone)
Size: 96.5 Kb